Symbiotec Pharmalab Shares Make Muted Stock Market Debut, Recover Ground In Later Trade
New Delhi: Symbiotec Pharmalab shares made a subdued stock market debut on Tuesday, September 1, but quickly recovered from early weakness as buying interest picked up after listing. The pharmaceutical and biotechnology company's shares listed at ₹978.20 on the BSE, a discount of 0.99% to the IPO issue price of ₹988. However, the stock reversed its initial losses and later climbed to ₹1,074.05,…
We haven't written up this one. Free Press Journal has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.
- Shein Shares Fall 10% in Market Debut Before Recouping Ground businessoffashion.com
